BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) Fundamental Analysis & Valuation

NASDAQ:BRKRP • US1167942077

Current stock price

298.34 USD
-3.88 (-1.28%)
Last:

This BRKRP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BRKRP Profitability Analysis

1.1 Basic Checks

  • In the past year BRKRP was profitable.
  • BRKRP had a positive operating cash flow in the past year.
  • BRKRP had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years BRKRP had a positive operating cash flow.
BRKRP Yearly Net Income VS EBIT VS OCF VS FCFBRKRP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • BRKRP's Return On Assets of -0.36% is fine compared to the rest of the industry. BRKRP outperforms 63.16% of its industry peers.
  • The Return On Equity of BRKRP (-0.92%) is better than 64.91% of its industry peers.
  • The Return On Invested Capital of BRKRP (4.32%) is better than 70.18% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BRKRP is below the industry average of 11.38%.
Industry RankSector Rank
ROA -0.36%
ROE -0.92%
ROIC 4.32%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.91%
ROIC(5y)9.93%
BRKRP Yearly ROA, ROE, ROICBRKRP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • BRKRP has a better Operating Margin (7.90%) than 63.16% of its industry peers.
  • In the last couple of years the Operating Margin of BRKRP has declined.
  • Looking at the Gross Margin, with a value of 47.13%, BRKRP is in line with its industry, outperforming 49.12% of the companies in the same industry.
  • BRKRP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.9%
PM (TTM) N/A
GM 47.13%
OM growth 3Y-24.07%
OM growth 5Y-9.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.99%
GM growth 5Y-0.06%
BRKRP Yearly Profit, Operating, Gross MarginsBRKRP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BRKRP Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKRP is destroying value.
  • Compared to 1 year ago, BRKRP has more shares outstanding
  • BRKRP has about the same amout of shares outstanding than it did 5 years ago.
  • BRKRP has a better debt/assets ratio than last year.
BRKRP Yearly Shares OutstandingBRKRP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BRKRP Yearly Total Debt VS Total AssetsBRKRP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BRKRP has an Altman-Z score of 8.70. This indicates that BRKRP is financially healthy and has little risk of bankruptcy at the moment.
  • BRKRP has a better Altman-Z score (8.70) than 91.23% of its industry peers.
  • BRKRP has a debt to FCF ratio of 131.63. This is a negative value and a sign of low solvency as BRKRP would need 131.63 years to pay back of all of its debts.
  • BRKRP has a Debt to FCF ratio of 131.63. This is comparable to the rest of the industry: BRKRP outperforms 49.12% of its industry peers.
  • BRKRP has a Debt/Equity ratio of 0.75. This is a neutral value indicating BRKRP is somewhat dependend on debt financing.
  • The Debt to Equity ratio of BRKRP (0.75) is worse than 75.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 131.63
Altman-Z 8.7
ROIC/WACC0.4
WACC10.78%
BRKRP Yearly LT Debt VS Equity VS FCFBRKRP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.73 indicates that BRKRP should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.73, BRKRP is not doing good in the industry: 77.19% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.86 indicates that BRKRP may have some problems paying its short term obligations.
  • BRKRP's Quick ratio of 0.86 is on the low side compared to the rest of the industry. BRKRP is outperformed by 89.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.86
BRKRP Yearly Current Assets VS Current LiabilitesBRKRP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BRKRP Growth Analysis

3.1 Past

  • BRKRP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.07%.
  • The Earnings Per Share has been growing slightly by 6.27% on average over the past years.
  • Looking at the last year, BRKRP shows a small growth in Revenue. The Revenue has grown by 2.08% in the last year.
  • The Revenue has been growing by 11.57% on average over the past years. This is quite good.
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.64% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.37% on average over the next years.
EPS Next Y18.09%
EPS Next 2Y16.09%
EPS Next 3Y16.04%
EPS Next 5Y13.64%
Revenue Next Year4.67%
Revenue Next 2Y4.22%
Revenue Next 3Y4.43%
Revenue Next 5Y4.37%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRKRP Yearly Revenue VS EstimatesBRKRP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
BRKRP Yearly EPS VS EstimatesBRKRP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. BRKRP Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 163.03, BRKRP can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of BRKRP is on the same level as its industry peers.
  • BRKRP is valuated expensively when we compare the Price/Earnings ratio to 26.78, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 138.05, BRKRP can be considered very expensive at the moment.
  • BRKRP's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, BRKRP is valued quite expensively.
Industry RankSector Rank
PE 163.03
Fwd PE 138.05
BRKRP Price Earnings VS Forward Price EarningsBRKRP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BRKRP.
  • BRKRP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 3198.12
EV/EBITDA 96.72
BRKRP Per share dataBRKRP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRKRP does not grow enough to justify the current Price/Earnings ratio.
  • BRKRP's earnings are expected to grow with 16.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.01
PEG (5Y)25.99
EPS Next 2Y16.09%
EPS Next 3Y16.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. BRKRP Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.53%, BRKRP is not a good candidate for dividend investing.
  • In the last 3 months the price of BRKRP has falen by -25.70%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.11, BRKRP pays a better dividend. On top of this BRKRP pays more dividend than 91.23% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, BRKRP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

  • On average, the dividend of BRKRP grows each year by 6.15%, which is quite nice.
  • BRKRP is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)6.15%
Div Incr Years1
Div Non Decr Years1
BRKRP Yearly Dividends per shareBRKRP Yearly Dividends per shareYearly Dividends per share 2025 2026 1 2 3

5.3 Sustainability

  • The earnings of BRKRP are negative and hence is the payout ratio. BRKRP will probably not be able to sustain this dividend level.
  • BRKRP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-146.22%
EPS Next 2Y16.09%
EPS Next 3Y16.04%
BRKRP Yearly Income VS Free CF VS DividendBRKRP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

More info and screens

Find the best dividend stocksShow peers with best dividend

BRKRP Fundamentals: All Metrics, Ratios and Statistics

BRUKER CORP - BRKR 6 3/8 09/01/28

NASDAQ:BRKRP (4/10/2026, 8:08:51 PM)

298.34

-3.88 (-1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners92.3%
Inst Owner ChangeN/A
Ins Owners26.93%
Ins Owner ChangeN/A
Market Cap45.41B
Revenue(TTM)3.44B
Net Income(TTM)-22.50M
Analysts79.09
Price Target385.52 (29.22%)
Short Float %0%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly Dividend0.22
Dividend Growth(5Y)6.15%
DP-146.22%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.4%
Min EPS beat(2)-10.9%
Max EPS beat(2)31.69%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)1.39%
EPS beat(12)8
Avg EPS beat(12)4.7%
EPS beat(16)11
Avg EPS beat(16)5.48%
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)-0.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)1
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.64%
PT rev (1m)0%
PT rev (3m)-2.1%
EPS NQ rev (1m)1.22%
EPS NQ rev (3m)-42.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.22%
Valuation
Industry RankSector Rank
PE 163.03
Fwd PE 138.05
P/S 13.21
P/FCF 3198.12
P/OCF 337.9
P/B 18.49
P/tB 4936.23
EV/EBITDA 96.72
EPS(TTM)1.83
EY0.61%
EPS(NY)2.16
Fwd EY0.72%
FCF(TTM)0.09
FCFY0.03%
OCF(TTM)0.88
OCFY0.3%
SpS22.58
BVpS16.14
TBVpS0.06
PEG (NY)9.01
PEG (5Y)25.99
Graham Number25.78
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -0.92%
ROCE 5.47%
ROIC 4.32%
ROICexc 4.6%
ROICexgc 9.68%
OM 7.9%
PM (TTM) N/A
GM 47.13%
FCFM 0.41%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.91%
ROIC(5y)9.93%
ROICexc(3y)8.9%
ROICexc(5y)13.25%
ROICexgc(3y)16.34%
ROICexgc(5y)22.09%
ROCE(3y)10.01%
ROCE(5y)12.56%
ROICexgc growth 3Y-29.19%
ROICexgc growth 5Y-14.74%
ROICexc growth 3Y-36.05%
ROICexc growth 5Y-19.66%
OM growth 3Y-24.07%
OM growth 5Y-9.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.99%
GM growth 5Y-0.06%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 131.63
Debt/EBITDA 3.77
Cap/Depr 54.56%
Cap/Sales 3.5%
Interest Coverage 3.83
Cash Conversion 27.32%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.86
Altman-Z 8.7
F-Score4
WACC10.78%
ROIC/WACC0.4
Cap/Depr(3y)70.11%
Cap/Depr(5y)91.82%
Cap/Sales(3y)3.51%
Cap/Sales(5y)3.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
EPS Next Y18.09%
EPS Next 2Y16.09%
EPS Next 3Y16.04%
EPS Next 5Y13.64%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%
Revenue Next Year4.67%
Revenue Next 2Y4.22%
Revenue Next 3Y4.43%
Revenue Next 5Y4.37%
EBIT growth 1Y-29.82%
EBIT growth 3Y-15.92%
EBIT growth 5Y0.46%
EBIT Next Year53.54%
EBIT Next 3Y21.21%
EBIT Next 5Y17.15%
FCF growth 1Y-89.56%
FCF growth 3Y-53.93%
FCF growth 5Y-42.95%
OCF growth 1Y-46.52%
OCF growth 3Y-21.17%
OCF growth 5Y-16.56%

BRUKER CORP - BRKR 6 3/8 09/01/28 / BRKRP Fundamental Analysis FAQ

What is the fundamental rating for BRKRP stock?

ChartMill assigns a fundamental rating of 3 / 10 to BRKRP.


What is the valuation status of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) stock?

ChartMill assigns a valuation rating of 2 / 10 to BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP). This can be considered as Overvalued.


What is the profitability of BRKRP stock?

BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) has a profitability rating of 4 / 10.


How financially healthy is BRUKER CORP - BRKR 6 3/8 09/01/28?

The financial health rating of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is 3 / 10.


What is the earnings growth outlook for BRUKER CORP - BRKR 6 3/8 09/01/28?

The Earnings per Share (EPS) of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is expected to grow by 18.09% in the next year.